These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16014068)

  • 21. Quantitative analysis of convective dose in hemofiltration and hemodiafiltration: "predilution" vs. "postdilution" reinfusion.
    Colussi G; Frattini G
    Hemodial Int; 2007 Jan; 11(1):76-85. PubMed ID: 17257360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles and practice of hemofiltration and hemodiafiltration.
    Ledebo I
    Artif Organs; 1998 Jan; 22(1):20-5. PubMed ID: 9456222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of filter life span and solute removal during continuous renal replacement therapy: convection versus diffusion - A randomized controlled trial.
    Xu Q; Jiang B; Li J; Lu W; Li J
    Ther Apher Dial; 2022 Oct; 26(5):1030-1039. PubMed ID: 34967496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
    Cirillo I; Vaccaro N; Balis D; Redman R; Matzke GR
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1187-93. PubMed ID: 21199922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coated carbon hemoperfusion provides limited clearance of protein-bound solutes.
    Dinh DC; Recht NS; Hostetter TH; Meyer TW
    Artif Organs; 2008 Sep; 32(9):717-24. PubMed ID: 18684207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome.
    Kellum JA; Johnson JP; Kramer D; Palevsky P; Brady JJ; Pinsky MR
    Crit Care Med; 1998 Dec; 26(12):1995-2000. PubMed ID: 9875910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficiency of different hollow-fiber hemofilters in continuous arteriovenous hemodiafiltration.
    Morabito S; Pierucci A; Marinelli R; Cicciarelli A; Guzzo I; Cinotti GA; Marino B; Chiavarelli R
    Am J Nephrol; 2000; 20(2):116-21. PubMed ID: 10773611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myoglobin clearance and removal during continuous venovenous hemofiltration.
    Amyot SL; Leblanc M; Thibeault Y; Geadah D; Cardinal J
    Intensive Care Med; 1999 Oct; 25(10):1169-72. PubMed ID: 10551978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dialysate and blood flow dependence of diffusive solute clearance during CVVHD.
    Relton S; Greenberg A; Palevsky PM
    ASAIO J; 1992; 38(3):M691-6. PubMed ID: 1457951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
    ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solute transport in continuous hemodialysis: a new treatment for acute renal failure.
    Sigler MH; Teehan BP
    Kidney Int; 1987 Oct; 32(4):562-71. PubMed ID: 3430952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arteriovenous hemodiafiltration associated with continuous arteriovenous hemofiltration: a combined therapy for acute renal failure in the hypercatabolic patient.
    Ronco C; Brendolan A; Bragantini L; Chiaramonte S; Fabris A; Feriani M; Dell'Aquila R; Milan M; La Greca G
    Blood Purif; 1987; 5(1):33-40. PubMed ID: 3790270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.
    Pham NM; Recht NS; Hostetter TH; Meyer TW
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):85-90. PubMed ID: 18045861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Con-Current versus Counter-Current Dialysate Flow during CVVHD. A Comparative Study for Creatinine and Urea Removal.
    Baldwin I; Baldwin M; Fealy N; Neri M; Garzotto F; Kim JC; Giuliani A; Basso F; Nalesso F; Brendolan A; Ronco C
    Blood Purif; 2016; 41(1-3):171-6. PubMed ID: 26764970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy.
    Leblanc M; Garred LJ; Cardinal J; Pichette V; Nolin L; Ouimet D; Geadah D
    Am J Kidney Dis; 1998 Sep; 32(3):444-53. PubMed ID: 9740161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance evaluation of developed polysulfone membrane hemodiafilters, ABH-F and ABH-P, in post- and pre-dilution hemodiafiltration.
    Sakiyama R; Yamamoto K; Ishimori I; Yoshida S; Akiba T; Mineshima M
    J Artif Organs; 2015 Dec; 18(4):330-7. PubMed ID: 26058830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous renal replacement therapy: evolution in technology and current nomenclature.
    Ronco C; Bellomo R
    Kidney Int Suppl; 1998 May; 66():S160-4. PubMed ID: 9573595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration.
    Krieter DH; Falkenhain S; Chalabi L; Collins G; Lemke HD; Canaud B
    Kidney Int; 2005 Jan; 67(1):349-56. PubMed ID: 15610261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.